Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.44 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4400297 | 0.97 | KMT2A (0.56) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| Bromide SCHEMBL2205844 | 0.95 | KMT2A (0.59) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| Hydrochloric Acid SCHEMBL344009 | 0.79 | KMT2A (0.52) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| Hydrochloric Acid SCHEMBL19031444 | 0.79 | KMT2A (0.52) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| SCHEMBL19037380 | 0.76 | KMT2A (0.54) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| SCHEMBL171879 | 0.76 | KMT2A (0.54) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| SCHEMBL16611634 | 0.76 | CYP2C9 (0.50) | KMT2ACYP2C9ACHE | |
| Hydrochloric Acid SCHEMBL1257629 | 0.75 | CYP2C9 (0.45) | KMT2ACYP2C9HSP90AA1POLBMAPK1 | |
| Hydrochloric Acid SCHEMBL614210 | 0.75 | KMT2A (0.48) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E | |
| Hydrazine SCHEMBL9553603 | 0.75 | KMT2A (0.48) | KMT2ACYP2C9HSP90AA1PABPC1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102953080-B | From containing the method reclaiming tellurium cadmium telluride assembly | GENERAL ELECTRIC COMPANY (US) | 2015-08-05 | — | — | CN | claimed |
| CN-102953080-A | Method for recovering tellurium from component containing cadmium telluride | GEN ELECTRIC | 2013-03-06 | — | — | CN | claimed |
| EP-4662206-A1 | GSPT1 DEGRADER COMPOUNDS | Captor Therapeutics S.A. (PL) | 2025-12-17 | — | — | EP | disclosed |
| EP-4630414-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | Captor Therapeutics S.A. (PL) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024167423-A1 | GSPT1 DEGRADER COMPOUNDS | CAPTOR THERAPEUTICS S.A. (PL) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024165577-A1 | GSPT1 DEGRADER COMPOUNDS | CAPTOR THERAPEUTICS S.A. (PL) | 2024-08-15 | — | — | WO | disclosed |
| WO-2024121256-A1 | TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN | CAPTOR THERAPEUTICS S.A. (PL) | 2024-06-13 | — | — | WO | disclosed |
| EP-3233801-B1 | USE OF PARTICULAR PYRIDINIUM SALTS FOR THE TREATMENT OF KERATIN SUBSTANCES, COMPOSITIONS AND IMPLEMENTATION METHODS | OREAL (FR) | 2022-06-08 | — | — | EP | disclosed |
| EP-2905361-B1 | METHOD OF FORMING A METAL COATING | TOYOTA MOTOR CO LTD (JP) | 2022-01-05 | — | — | EP | disclosed |
| CN-106999394-B | Use, composition and implementation method of specific pyridinium salt for treating keratin materials | 欧莱雅 | 2021-09-24 | — | — | CN | disclosed |
| EP-2607348-B1 | Plasminogen Activator Inhibitor-1 Inhibitor | RENASCIENCE INC (JP) | 2021-03-17 | — | — | EP | disclosed |
| EP-0798304-A1 | REMEDIES FOR THROMBOCYTOPENIA | SUNTORY LIMITED (JP) | 1997-10-01 | — | — | EP | disclosed |
| US-5534622-A | Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers | COMPAGNIE ORIS INDUSTRIE, SA (FR) | 1996-07-09 | — | — | US | disclosed |
| US-5457185-A | Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers | SOCIETE ANONYME: COMPAGNIE ORIS INDUSTRIE (FR) | 1995-10-10 | — | — | US | disclosed |
| EP-0357731-B1 | A NOVEL SPECTROFLUOROMETRIC METHOD AND COMPOUNDS THAT ARE OF VALUE FOR THE METHOD | WALLAC OY (FI) | 1994-11-30 | — | — | EP | disclosed |
| US-5346996-A | Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers | COMPAGNIE ORIS INDUSTRIE (FR) | 1994-09-13 | — | — | US | disclosed |
| US-5216134-A | Using two different chelates as probes | WALLAC OY (FI) | 1993-06-01 | — | — | US | disclosed |
| US-5162508-A | Rare earth cryptates, processes for their preparation, synthesis intermediates and application as fluorescent tracers | COMPAGNIE ORIS INDUSTRIE (FR) | 1992-11-10 | — | — | US | disclosed |
| EP-0357731-A1 | A NOVEL SPECTROFLUOROMETRIC METHOD AND COMPOUNDS THAT ARE OF VALUE FOR THE METHOD. | WALLAC OY (FI) | 1990-03-14 | — | — | EP | disclosed |
| WO-1989008263-A1 | A NOVEL SPECTROFLUOROMETRIC METHOD AND COMPOUNDS THAT ARE OF VALUE FOR THE METHOD | WALLAC OY (FI) | 1989-09-08 | — | — | WO | disclosed |